JT and ME contributed equally to this work.
Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial
Version of Record online: 15 FEB 2013
Copyright © 2013 American Society for Bone and Mineral Research
Journal of Bone and Mineral Research
Volume 28, Issue 3, pages 464–471, March 2013
How to Cite
Welton, J. L., Morgan, M. P., Martí, S., Stone, M. D., Moser, B., Sewell, A. K., Turton, J. and Eberl, M. (2013), Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: Insights from a phase IV safety trial. J Bone Miner Res, 28: 464–471. doi: 10.1002/jbmr.1797
- Issue online: 15 FEB 2013
- Version of Record online: 15 FEB 2013
- Accepted manuscript online: 16 OCT 2012 08:11AM EST
- Manuscript Accepted: 8 OCT 2012
- Manuscript Revised: 2 OCT 2012
- Manuscript Received: 11 JUN 2012
Additional Supporting Information may be found in the online version of this article.
|jbmr_1797_sm_SupplFigS1.tif||4637K||Supplementary Figure S1|
|jbmr_1797_sm_SupplFigS2.tif||2984K||Supplementary Figure S2|
|jbmr_1797_sm_SupplFigsLegend.doc||34K||Supplementary Figures Legend|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.